Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 254-260 , December 2007

Evaluation of ALA-PDT of ovarian cancer in the Fisher 344 rat tumor model

  • Manuel Ascencio

      Affiliations

    • Department of Gynecology and Obstetrics, Lille University Hospital, Lille, France
    • INSERM (French National Institute of Health and Medical Research) IFR 114 & Lille University Hospital, Lille, France
    • ,
  • Marie Delemer

      Affiliations

    • Department of Gynecology and Obstetrics, Lille University Hospital, Lille, France
    • INSERM (French National Institute of Health and Medical Research) IFR 114 & Lille University Hospital, Lille, France
    • ,
  • M.O. Farine

      Affiliations

    • Department of Anatomo-Pathology, Lille University Hospital, Lille, France
    • ,
  • Eva Jouve

      Affiliations

    • Department of Gynecology and Obstetrics, Lille University Hospital, Lille, France
    • INSERM (French National Institute of Health and Medical Research) IFR 114 & Lille University Hospital, Lille, France
    • ,
  • Pierre Collinet

      Affiliations

    • Department of Gynecology and Obstetrics, Lille University Hospital, Lille, France
    • ,
  • Serge Mordon, PhD

      Affiliations

    • INSERM (French National Institute of Health and Medical Research) IFR 114 & Lille University Hospital, Lille, France
    • Corresponding Author InformationCorresponding author at: INSERM (French National Institute of Health and Medical Research) IFR 114, Pavillon Vancostenobel, Lille University Hospital, 59037 Lille Cedex, France. Tel.: +33 320 446 708; fax: +33 320 446 708.

References 

  1. Benedet JL, Bender H, Jones H, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000;70(2):209–262
  2. Remontet L, Estève J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Santé Publique. 2003;51:3–30
  3. Eisenkop SM, Nalick RH, Wang HJ, Teng NN. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol. 1993;51(2):224–229
  4. McCarron PA, Donnelly RF, Zawislak A, Woolfson AD, Price JH, McClelland R. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int J Pharm. 2005;293(1–2):11–23
  5. McCarron PA, Ma LW, Juzenas P, et al. Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems. J Environ Pathol Toxicol Oncol. 2006;25(1–2):389–402
  6. Hillemanns P, Wang X, Staehle S, Michels W, Dannecker C. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol. 2006;100(2):271–275
  7. Saah-Briffaut E, Collinet P, Saah R, Boman F, Leroy JL. [Treatment of squamous intraepithelial lesion of type CIN2 et CIN3 with laser CO2 vaporization: retrospective study of 52 cases]. J Gynecol Obstet Biol Reprod (Paris). 2006;35(8 Pt 1):785–789
  8. Yamaguchi S, Tsuda H, Takemori M, et al. Photodynamic therapy for cervical intraepithelial neoplasia. Oncology. 2005;69(2):110–116
  9. Zaak D, Sroka R, Stocker S, et al. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX – in vivo experiments on the dunning rat tumor model. Urol Int. 2004;72(3):196–202
  10. El Khatib S, Didelon J, Leroux A, Bezdetnaya L, Notter D, D’Hallewin M. Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. J Urol. 2004;172(5 Pt 1):2013–2017
  11. Gossner L, Sroka R, Hahn EG, Ell C. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc. 1995;41(1):55–58
  12. Pech O, Gossner L, May A, et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc. 2005;62(1):24–30
  13. Regula J, Ravi B, Bedwell J, MacRobert AJ, Bown SG. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer—prolonged animal survival. Br J Cancer. 1994;70(2):248–254
  14. Ziolkowski P, Osiecka BJ, Oremek G, et al. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture. J Exp Ther Oncol. 2004;4(2):121–129
  15. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine. Br J Dermatol. 1995;133(2):282–288
  16. Betz CS, Lai JP, Xiang W, et al. In vitro photodynamic therapy of nasopharyngeal carcinoma using 5-aminolevulinic acid. Photochem Photobiol Sci. 2002;1(5):315–319
  17. Henderson BW, Dougherty TJ. How does photodynamic therapy work?. Photochem Photobiol. 1992;55(1):145–157
  18. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14(4):275–292
  19. Loning MC, Diddens HC, Holl-Ulrich K, et al. Fluorescence staining of human ovarian cancer tissue following application of 5-aminolevulinic acid: Fluorescence microscopy studies. Lasers Surg Med. 2006;
  20. Haddad R, Kaplan O, Greenberg R, Siegal A, Skornick Y, Kashtan H. Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitizer. Int J Surg Investig. 2000;2(3):171–178
  21. Buchczyk DP, Klotz LO, Lang K, Fritsch C, Sies H. High efficiency of 5-aminolevulinate-photodynamic treatment using UVA irradiation. Carcinogenesis. 2001;22(6):879–883
  22. Boere IA, Robinson DJ, de Bruijn HS, van den Boogert J, Tilanus HW, Sterenborg HJ. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol. 2003;78(3):271–277
  23. Rose GS, Tocco LM, Granger GA, et al. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol. 1996;175(3 Pt 1):593–599
  24. Hornung R, Fink D, Dobler-Girdziunaite D, Stallmach T, Haller U, Walt H. Photodynamic therapy for the hypercalcemic type of the small cell carcinoma of the ovary in a mouse xenograft model. Gynecol Oncol. 1999;75(3):447–452
  25. Major AL, Rose GS, Svaasand LO, Ludicke F, Campana A, van Gemert MJ. Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: a toxicity study. J Photochem Photobiol B. 2002;66(2):107–114
  26. Hendren SK, Hahn SM, Spitz FR, et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol. 2001;8(1):65–71
  27. Sporri S, Chopra V, Egger N, et al. Effects of 5-aminolaevulinic acid on human ovarian cancer cells and human vascular endothelial cells in vitro. J Photochem Photobiol B. 2001;64(1):8–20
  28. Shahzidi S, Stokke T, Soltani H, Nesland JM, Peng Q. Induction of apoptosis by hexaminolevulinate-mediated photodynamic therapy in human colon carcinoma cell line 320DM. J Environ Pathol Toxicol Oncol. 2006;25(1–2):159–171
  29. Furre IE, Moller MT, Shahzidi S, Nesland JM, Peng Q. Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells. Apoptosis. 2006;11(11):2031–2042
  30. Furre IE, Shahzidi S, Luksiene Z, et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res. 2005;65(23):11051–11060
  31. Etienne J, Dorme N, Bourg-Heckly G, Raimbert P, Flejou JF. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc. 2004;59(7):880–889
  32. Grosjean P, Wagnieres G, Fontolliet C, van den Bergh H, Monnier P. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514nm compared with 630nm light irradiation after sensitization with Photofrin II. Br J Cancer. 1998;77(11):1989–1995
  33. Dougherty TJ. Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol. 1984;2(2):83–116
  34. McCaughan JS, Hicks W, Laufman L, May E, Roach R. Palliation of esophageal malignancy with photoradiation therapy. Cancer. 1984;54(12):2905–2910
  35. Hornung R, Fehr MK, Monti-Frayne J, et al. Highly selective targeting of ovarian cancer with the photosensitizer PEG-m-THPC in a rat model. Photochem Photobiol. 1999;70(4):624–629
  36. Hornung R, Fehr MK, Monti-Frayne J, Tromberg BJ, Berns MW, Tadir Y. Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC. Br J Cancer. 1999;81(4):631–637
  37. Waidelich R, Beyer W, Knuchel R, et al. Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source. Urology. 2003;61(2):332–337
  38. Mordon S, Maunoury V. Using white light during photodynamic therapy: visualization only or treatment?. Eur J Gastroenterol Hepatol. 2006;18(7):765–771
  39. Collinet P, Sabban F, Cosson M, et al. Laparoscopic photodynamic diagnosis of ovarian cancer peritoneal micro metastasis: An experimental study. Photochem Photobiol. 2007;83:647–651

PII: S1572-1000(07)00072-5

doi: 10.1016/j.pdpdt.2007.07.003

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 254-260 , December 2007

Article Tools

* Image Usage & Resolution